[Comparison between results achieved by administering L-dopa and Sinemet in parkinsonism in the light of our records]
- PMID: 1186952
[Comparison between results achieved by administering L-dopa and Sinemet in parkinsonism in the light of our records]
Abstract
On the basis of observations of 18 patients the authors evaluated clinically the action of Sinement preparation (Merch, Sharp and Dohme) containing L-dopa 250 mg and carbidopa 25 mg in the treatment of Parkinson's disease. In the evaluation particular attention was given to side effects. Therapeutic results of Sinemet and L-dopa alone were compared in patients receiving these drugs alternatively. The observations of authors indicate that Sinemet gives the same therapeutic results as L-dopa, but in much lower doses and with less frequent side effects. Sinemet, similarly as L-dopa exerts the best effect on bradykinesia and muscular rigidity and less on tremor.
Similar articles
-
[The combined treatment of Parkinson's disease with L-dopa plus decarboxylase inhibitors (carbidopa, benserazide) (author's transl)].Wien Klin Wochenschr. 1979 May 11;91(10):332-7. Wien Klin Wochenschr. 1979. PMID: 452602 Clinical Trial. German.
-
L-dopa and carbidopa (sinemet) in the management of parkinsonism.Postgrad Med J. 1975 Sep;51(599):619-21. doi: 10.1136/pgmj.51.599.619. Postgrad Med J. 1975. PMID: 1105500 Free PMC article. Clinical Trial.
-
[Treatment of Parkinson's disease with levodopa and a dopa decarboxylase inhibitor].Neurol Neurocir Psiquiatr. 1976;17(4):293-300. Neurol Neurocir Psiquiatr. 1976. PMID: 1018729 Spanish.
-
Factors associated with motor fluctuations and dyskinesia in Parkinson Disease: potential role of a new melevodopa plus carbidopa formulation (Sirio).Clin Neuropharmacol. 2010 Jul;33(4):198-203. doi: 10.1097/WNF.0b013e3181de8924. Clin Neuropharmacol. 2010. PMID: 20414107 Review.
-
Sinemet and the treatment of Parkinsonism.Ann Intern Med. 1981 Mar;94(3):364-70. doi: 10.7326/0003-4819-94-3-364. Ann Intern Med. 1981. PMID: 7013595 Review.